项目名称: 纤维胶凝蛋白激活的补体凝集素途径抵抗弓形虫感染及机制研究
项目编号: No.31502059
项目类型: 青年科学基金项目
立项/批准年度: 2016
项目学科: 水产学、兽医学
项目作者: 聂浩
作者单位: 长江大学
项目金额: 21万元
中文摘要: 弓形虫病由刚地弓形虫引起,是一种在世界范围内广泛流行的人兽共患寄生虫病,一线抗弓形虫药仅仅能够压制弓形虫血症并不能够彻底治疗弓形虫病;故迫切需要寻找新的抗弓形虫药物或药物靶点。纤维胶凝蛋白(ficolin)能够通过识别病原(病毒、细菌和真菌)表面的糖链或糖蛋白激活MBL途径、调理巨噬细胞对病原的吞噬作用,有作为抗病原药物潜力;巨噬细胞在抵抗弓形虫感染中的重要作用已获公认,但激活补体系统抗弓形虫感染机制尚未厘清,且ficolin在抗弓形虫感染中的保护作用和识别弓形虫细胞上膜糖链或糖蛋白的种类也没有阐明。本研究构建人和小鼠的ficolin原核/真核载体表达获得重组ficolin蛋白,进行体内/体外试验,研究ficolin蛋白保护宿主或细胞抵御弓形虫感染作用,寻找弓形虫细胞上ficolin所识别膜糖链或糖蛋白,为开发新的抗弓形虫药物提供立论依据,同时也能够为其他顶器门病原生物的防控提供新的思路。
中文关键词: 刚地弓形虫;纤维胶凝蛋白;凝集素途径;新型抗弓形虫药物
英文摘要: Toxoplasmosis, caused by Toxoplasma gondii, is widely spread in warm-blooded animals and human beings. The drugs that currently used to treat toxoplasmosis can only kill the tachyzoites but not able to cure toxoplasmosis completely.Therefore, there is an urgent need to find new anti-Toxoplasma drugs or drug targets.Previous works had shown that the ficolin could activate MBL pathway and regulate the pathogen phagocytosis of macrophages by recognizing the glycoproteins or sugar side chains on the surface of pathogens (viruses, bacteria and fungi). It was widely accepted that macrophages played an important role in Toxoplasma gondii infection defense, but the mechanism of the complement system activation in defending Toxoplasma gondii infection has not been clarified. The protective effect for ficolin molecules in anti-toxoplasma infection and the sugar chains or glycoproteins on Toxoplasma gondii cell surface that can be recognized by ficolin molecules are still unclear.This study intends to evaluate the protective effect of ficolin on Toxoplasma gondii infected-hosts/host-cells in the mice/cell model by expressing both human’s and mice’s ficolin genes using the prokaryotic and eukaryotic expression vectors respectively, and then evaluate the possibility of developing ficolin as a new anti-Toxoplasma drug. In addition, this study will also provide us a new idea in developing new preventive or therapeutic strategies for other Apicomplexa parasites.
英文关键词: Toxoplasma gondii;ficolin;lectin-pathway;new anti-toxoplasma drugs